FDA Approved: GLIMEPIRIDE — Supplemental Application (Solco Healthcare U.S., LLC)

View source ↗

Summary

The FDA approved a supplemental application for glimepiride, enabling Solco Healthcare U.S., LLC to market a generic version of this diabetes medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glimepiride (glimepiride)

Snippet

SUPPL AP for GLIMEPIRIDE (GLIMEPIRIDE)